인테라

Protein Nanoparticle (PNP)based Recombinant Vaccine Platform

Development of various new vaccines with efficacy and stability by utilizing microorganism-based One-Component Nanoparticle Vaccine Platform

Benefits of VLNP

• 1Efficient and stable antigen delivery

• 2Highly-dense & regular antigen presentation

  Efficient induction of
  immune responses

• 3Efficient induction of humoral
  immune response as well as cellular immune responses

• 4Biodegradable & low reactogenicity

  Safety